Literature DB >> 27534417

The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.

Shenshan Zou1,2, Yufu Zhu1,3, Bin Wang1,2, Fengyuan Qian1,2, Xiang Zhang1,2, Lei Wang1,3, Chunling Fu4, Hanmo Bao1,2, Manyi Xie1,3, Shangfeng Gao1,3, Rutong Yu5,6, Hengliang Shi7,8.   

Abstract

Human glioma causes substantial morbidity and mortality worldwide. However, the molecular mechanisms underlying glioma progression are still largely unknown. COP1 (constitutively photomorphogenic 1), an E3 ubiquitin ligase, is important in cell survival, development, cell growth, and cancer biology by regulating different substrates. As is well known, both tumor suppressor p53 and oncogenic protein c-JUN could be ubiquitinated and degraded by ubiquitin ligase COP1, which may be the reason that COP1 serves as an oncogene or a tumor suppressor in different cancer types. Up to now, the possible role of COP1 in human glioma is still unclear. In the present study, we found that the expression of COP1 was upregulated in human glioma tissues. The role of COP1 in glioma cell proliferation was investigated using COP1 loss- and gain-of-function. The results showed that downregulation of COP1 by short hairpin RNA (shRNA) inhibited glioma cell proliferation, while overexpression of COP1 significantly promoted it. Furthermore, we demonstrated that COP1 only interacted with and regulated p53, but not c-JUN. Taken together, these results indicate that COP1 may play a role in promoting glioma cell proliferation by interacting with and downregulating tumor suppressor p53 rather than oncogenic protein c-JUN.

Entities:  

Keywords:  C-JUN; COP1; Glioma; Ubiquitin ligase; p53

Mesh:

Substances:

Year:  2016        PMID: 27534417     DOI: 10.1007/s12035-016-0033-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

1.  TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.

Authors:  Ling Qi; Jose E Heredia; Judith Y Altarejos; Robert Screaton; Naomi Goebel; Sherry Niessen; Ian X Macleod; Chong Wee Liew; Rohit N Kulkarni; James Bain; Christopher Newgard; Michael Nelson; Ronald M Evans; John Yates; Marc Montminy
Journal:  Science       Date:  2006-06-23       Impact factor: 47.728

2.  COP1 is a tumour suppressor that causes degradation of ETS transcription factors.

Authors:  Alberto C Vitari; Kevin G Leong; Kim Newton; Cindy Yee; Karen O'Rourke; Jinfeng Liu; Lilian Phu; Rajesh Vij; Ronald Ferrando; Suzana S Couto; Sankar Mohan; Ajay Pandita; Jo-Anne Hongo; David Arnott; Ingrid E Wertz; Wei-Qiang Gao; Dorothy M French; Vishva M Dixit
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

3.  Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.

Authors:  Gang Lu; Qing Zhang; Ying Huang; Jiaxi Song; Ross Tomaino; Tobias Ehrenberger; Elgene Lim; Wenbin Liu; Roderick T Bronson; Michaela Bowden; Jane Brock; Ian E Krop; Deborah A Dillon; Steven P Gygi; Gordon B Mills; Andrea L Richardson; Sabina Signoretti; Michael B Yaffe; William G Kaelin
Journal:  Cancer Cell       Date:  2014-08-11       Impact factor: 31.743

Review 4.  Spotlight on the role of COP1 in tumorigenesis.

Authors:  Jean-Christophe Marine
Journal:  Nat Rev Cancer       Date:  2012-06-07       Impact factor: 60.716

5.  COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression.

Authors:  Satomi Kato; Jixin Ding; Evan Pisck; Ulupi S Jhala; Keyong Du
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

6.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

Review 7.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

8.  E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.

Authors:  Da-Qiang Li; Kazufumi Ohshiro; Sirigiri Divijendra Natha Reddy; Suresh B Pakala; Mong-Hong Lee; Yanping Zhang; Suresh K Rayala; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-24       Impact factor: 11.205

9.  Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity.

Authors:  Elisabetta Bianchi; Simona Denti; Raffaella Catena; Grazisa Rossetti; Simona Polo; Sona Gasparian; Stella Putignano; Lars Rogge; Ruggero Pardi
Journal:  J Biol Chem       Date:  2003-03-03       Impact factor: 5.157

10.  COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer.

Authors:  Mao Ouyang; Hua Wang; Jieyi Ma; Weiming Lü; Jie Li; Chen Yao; Guangqi Chang; Jiong Bi; Shenming Wang; Wenjian Wang
Journal:  BMC Cancer       Date:  2015-03-15       Impact factor: 4.430

View more
  16 in total

1.  TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.

Authors:  Yufu Zhu; Yang Xu; Tianze Chen; Yujian Zhang; Qiang Ma; Sunil Rauniyar; Lei Wang; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

2.  COP1 Acts as a Ubiquitin Ligase for PCDH9 Ubiquitination and Degradation in Human Glioma.

Authors:  Kunlin Zhou; Lei Wang; Zhiyuan Sun; Yuelin Liu; Yufu Zhu; Zhiyi Liu; Bin Zhang; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

3.  [Effects of ring finger and tryptophan-aspartic acid 2 on dendritic spines and synapse formation in cerebral cortex neurons of mice].

Authors:  T Sun; Y Wang; Z Fang; J Xu; S Ma; J Chang; G Liu; Y Guo; C Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

4.  The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.

Authors:  Kateryna Shostak; Alain Chariot; Seng Chuan Tang; Quentin Lion; Olivier Peulen; Philippe Chariot; Arnaud Lavergne; Alice Mayer; Paula Allepuz Fuster; Pierre Close; Sebastian Klein; Alexandra Florin; Reinhard Büttner; Ivan Nemazanyy
Journal:  Oncogene       Date:  2021-10-29       Impact factor: 9.867

5.  RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.

Authors:  Songwang Xie; Zhen Hong; Yan Li; Junyong Wang; Jian Wang; Shaoquan Li; Yongchang Liu
Journal:  Mol Neurobiol       Date:  2022-05-20       Impact factor: 5.682

Review 6.  Anticancer Actions of Azurin and Its Derived Peptide p28.

Authors:  Fan Huang; Qianhui Shu; Zhaojie Qin; Jianglin Tian; Zhengding Su; Yongqi Huang; Meng Gao
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

7.  SHARPIN Facilitates p53 Degradation in Breast Cancer Cells.

Authors:  Huijie Yang; Sifan Yu; Weilong Wang; Xin Li; Yingxiang Hou; Zhenhua Liu; Yuanyuan Shi; Kun Mu; Gang Niu; Juntao Xu; Hui Wang; Jian Zhu; Ting Zhuang
Journal:  Neoplasia       Date:  2017-01-05       Impact factor: 5.715

Review 8.  Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.

Authors:  Sanam Sane; Khosrow Rezvani
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

9.  Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.

Authors:  Yufu Zhu; Xiang Zhang; Lei Wang; Zhe Ji; Manyi Xie; Xinyu Zhou; Zhiyi Liu; Hengliang Shi; Rutong Yu
Journal:  J Cell Mol Med       Date:  2017-05-04       Impact factor: 5.310

10.  Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.

Authors:  Ilaria Moscetti; Anna Rita Bizzarri; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2018-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.